U.S. Breast Reconstruction Market Size, Share & Trends Analysis Report by Product (Implants, Tissue Expander, Acellular Dermal Matrix), Shape (Round, Anatomical), End-Use with Growth Forecasts, 2025-2030

The U.S. Breast Reconstruction Market was valued at USD 1.12 billion in 2024, and is projected to reach USD 1.65 billion by 2030, rising at a CAGR of 6.80%. The market is experiencing significant growth due to the increasing number of breast cancer survivors seeking reconstruction, growing awareness about breast cancer treatments, and advancements in surgical techniques. In addition, the availability of insurance coverage for reconstruction procedures and the increasing adoption of minimally invasive methods contribute to market growth. As more women undergo mastectomies and look for options to restore breast appearance, the demand for these procedures continues to rise.

New product launches and FDA approvals in the U.S. breast reconstruction market drive significant breast reconstruction advancements by promoting innovation, enhancing safety standards, and improving clinical outcomes. In October 2023, Establishment Labs announced the FDA clearance of their Motiva Flora SmoothSilk Tissue Expander, the first of its kind to receive FDA clearance in the U.S. The Motiva Flora expander eliminates the use of magnets in the filling port, making it MRI-conditional. It allows unimpeded MRI scans, crucial for post-surgical monitoring and cancer screening. This innovation by Establishment Labs has the potential to streamline the breast reconstruction process for patients who require MRI scans.

The U.S. breast reconstruction market is witnessing a significant shift toward tissue expanders as patients increasingly prefer this technology. Tissue expanders, also known as tissue expander systems, are implantable devices used to stretch and expand the skin & soft tissues in preparation for breast reconstruction surgery. This technology has gained popularity due to its ability to provide a more natural look and feel, as well as reduced recovery time & scarring. Tissue expanders are used to extend the breast pocket following a mastectomy so that a breast implant can be placed. Two-stage expander-to-implant breast reconstruction accounts for more than half of all breast reconstruction surgeries in the U.S. In the last few decades, tissue expansion technology has significantly advanced.

U.S. Breast Reconstruction Market Report Highlights

• Based on product, the implants segment dominates the market with the largest revenue share owing to their ability to provide natural-looking results, shorter recovery times, and lower risk compared to other options like tissue flaps.
• Based on shape, the round segment dominate the market with the largest revenue share because they offer a fuller, more symmetrical appearance, which many patients prefer.
• Based on end use, the hospitals dominated the market with the largest revenue share. Hospitals perform the highest number of mastectomy and reconstruction surgeries.

This report addresses:

• Market intelligence to enable effective decision-making.
• Market estimates and forecasts from 2018 to 2030.
• Growth opportunities and trend analyses.
• Segment and regional revenue forecasts for market assessment.
• Competition strategy and market share analysis.
• Product innovation listings for you to stay ahead of the curve.
• COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

• Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
• Competitive Landscape: Explore the market presence of key players.
• Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
• Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.